首页|BNIP3-mediated mitophagy attenuates hypoxic-ischemic brain damage in neonatal rats by inhibiting ferroptosis through P62-KEAP1-NRF2 pathway activation to maintain iron and redox homeostasis

BNIP3-mediated mitophagy attenuates hypoxic-ischemic brain damage in neonatal rats by inhibiting ferroptosis through P62-KEAP1-NRF2 pathway activation to maintain iron and redox homeostasis

扫码查看
原文链接
  • NETL
  • NSTL
  • 万方数据
As a major contributor to neonatal death and neurological sequelae,hypoxic-ischemic encephalopathy(HIE)lacks a viable medication for treatment.Oxidative stress induced by hypoxic-ischemic brain damage(HIBD)predisposes neurons to ferroptosis due to the fact that neonates accumulate high levels of polyunsaturated fatty acids for their brain developmental needs but their antioxidant capacity is immature.Ferroptosis is a form of cell death caused by excessive accumulation of iron-dependent lipid peroxidation and is closely associated with mitochondria.Mitophagy is a type of mitochondrial quality control mechanism that degrades damaged mitochondria and maintains cellular homeostasis.In this study we employed mitophagy agonists and inhibitors to explore the mechanisms by which mitophagy exerted ferroptosis resistance in a neonatal rat HIE model.Seven-days-old neonatal rats were subjected to ligation of the right common carotid artery,followed by exposure to hypoxia for 2 h.The neonatal rats were treated with a mitophagy activator Tat-SPK2 peptide(0.5,1 mg/kg,i.p.)1 h before hypoxia,or in combination with mitochondrial division inhibitor-1(Mdivi-1,20 mg/kg,i.p.),and ferroptosis inhibitor Ferrostatin-1(Fer-1)(2 mg/kg,i.p.)at the end of the hypoxia period.The regulation of ferroptosis by mitophagy was also investigated in primary cortical neurons or PC1 2 cells in vitro subjected to 4 or 6 h of OGD followed by 24 h of reperfusion.We showed that HIBD induced mitochondrial damage,ROS overproduction,intracellular iron accumulation,lipid peroxidation and ferroptosis,which were significantly reduced by the pretreatment with Tat-SPK2 peptide,and aggravated by the treatment with Mdivi-1 or BNIP3 knockdown.Ferroptosis inhibitors Fer-1 and deferoxamine B(DFO)reversed the accumulation of iron and lipid peroxides caused by Mdivi-1,hence reducing ferroptosis triggered by HI.We demonstrated that Tat-SPK2 peptide-activated BNIP3-mediated mitophagy did not alleviate neuronal ferroptosis through the GPX4-GSH pathway.BNIP3-mediated mitophagy drove the P62-KEAP1-NRF2 pathway,which conferred ferroptosis resistance by maintaining iron and redox homeostasis via the regulation of FTH1,HO-1,and DHODH/FSP1-CoQ10-NADH.This study may provide a new perspective and a therapeutic drug for the treatment of neonatal HIE.

hypoxic-ischemic brain damagemitophagyferroptosisTat-SPK2 peptideP62-KEAP1-NRF2 pathway

Xin-xin Wang、Mei Li、Xiao-wen Xu、Wen-bin Zhao、Yi-ming Jin、Li-li Li、Zheng-hong Qin、Rui Sheng、Hong Ni

展开 >

Department of Brain Research,Institute of Pediatric Research,Children's Hospital of Soochow University,Suzhou 215025,China

Department of Pharmacology and Laboratory of Aging and Nervous Diseases,Soochow University School of Pharmaceutical Science,Suzhou,199 Ren Ai Road,Suzhou 215123,China

Institute of Heath Technology,Global Institute of Software Technology,Qingshan Road,Suzhou Science & Technology Tower,Hi-Tech Area,Suzhou 215163,China

2025

10.1038/s41401-024-01365-x

中国药理学报(英文版)
中科院上海药物研究所

中国药理学报(英文版)

影响因子：0.926
ISSN：1671-4083
年,卷(期)：2025.46(1)